Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026)
Butterfly Network (BFLY) posted Cash from Financing Activities of $3.9 million for Q2 2026, up 70.98% sequentially from $2.3 million in Q1 2026, and up 300.0% YoY from $987000.0 in Q2 2025.
Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Butterfly Network has reported Cash from Financing Activities for 7 years, with the latest figure at $3.9 million in Q2 2026.
- Quarterly Cash from Financing Activities rose 300.0% year-over-year to $3.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.6 million (down 94.14% YoY) and the FY2025 annual result came in at $77.8 million, up 5301.47% from the prior year.
- Cash from Financing Activities improved to $3.9 million in Q2 2026 per BFLY's latest filing, from $2.3 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $78.5 million in Q1 2025 and troughed at -$1.7 million in Q4 2025.
- A 5-year average of $7.1 million and a median of $354500.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities plunged 99.9% in 2022, then soared 300.0% in 2026.
- Over 5 years, Cash from Financing Activities stood at $137000.0 in 2022, then slumped by 32.85% to $92000.0 in 2023, then slumped by 1725.0% to -$1.5 million in 2024, then retreated by 13.18% to -$1.7 million in 2025, then jumped by 333.33% to $3.9 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $3.9 million, $2.3 million, and -$1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Butterfly Network | 2.41 Bn | 2.29 Bn | 23.29 Mn | 3.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.95 Mn |
| Jun 30, 2026 | 3.95 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 78.47 Mn |
| Mar 31, 2025 | 78.47 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.04 Mn |